Research and Development

Showing 15 posts of 9573 posts found.

Modified mice could speed safe drug discoveries

October 27, 2006 Research and Development

 CXR Biosciences, based in Scotland, and Artemis Pharmaceuticals in Germany, have been granted licences to sell their genetically modified mice, …

Cerovive failure another blow for AstraZeneca

October 26, 2006 Research and Development, Sales and Marketing AstraZeneca, Cerovive, neuroscience

 A drug which had held out the promise of reducing the disabling effects of stroke on patients will be abandoned …

Lilly underlines its position as major biotech company

October 25, 2006 Research and Development

Eli Lilly has opened the first phase of a $560 million expansion to its US biotech research complex.The news comes …

Pfizer buys British vaccine company PowderMed

October 12, 2006 Research and Development Pfizer, Powdermed, vaccines

Pfizer will gain entry into the fast-growing vaccines market by buying PowderMed, the British company developing next generation products in …

Amgen to acquire Avidia

October 5, 2006 Research and Development, Sales and Marketing

Amgen is to pay $290 million to buy Avidia, a Californian biotech company which is developing innovative new protein-based medicines.Based …

Novartis’ MS drug shows further promise

October 2, 2006 Research and Development

A new treatment for multiple sclerosis currently being developed by Novartis has shown further promise in slowing the progress of …

Two new AstraZeneca laboratories opened in UK

September 29, 2006 Research and Development

AstraZeneca has officially opened two major research laboratories in the UK, which it says demonstrates its commitment to R&D in …

AZ and Schering take novel approach in cancer collaboration

September 22, 2006 Research and Development

AstraZeneca and Schering are to co-develop a promising new drug candidate to treat breast cancer, with the two partners taking …

NicOx to develop enhanced statin product

September 6, 2006 Research and Development

NicOx is to develop a new statin treatment using its special in-house technology which, according to the company, could make …

Collaboration to develop new Parkinson’s Disease dyskinesia treatment

September 6, 2006 Research and Development

Santhera Pharmaceuticals is collaborating with Finnish biotech company Juvantia Pharma to develop a treatment for dyskinesia, the distressing involuntary movements …

AstraZeneca and charity spin-off collaborate on colorectal cancer research

September 4, 2006 Research and Development

AstraZeneca is to work with a spin-off company set up by Cancer Research UK to research and develop new treatments …

Women’s European pharma network launched

September 1, 2006 Research and Development, Sales and Marketing Europe, association, pharma

 Over the years, the numbers of women taking up positions of authority in the pharmaceutical industry has grown considerably, and …

The right stuff: execs with the Midas touch

August 31, 2006 Business Services, Research and Development biotech, management, recruitment

Here's a challenge: find someone with PhD-level scientific knowledge, a strong management track record and entrepreneurial flair. If there are …

GSK signs $1.5 billion drug discovery deal

August 31, 2006 Research and Development

GlaxoSmithKline has formed an alliance with Californian biotech company ChemoCentryx through its innovative drug development partnering unit.A licensing deal has …

MabThera shows promise in multiple sclerosis

August 29, 2006 Research and Development

The blockbuster non-Hodgkin's lymphoma treatment MabThera could offer a new treatment option for people with multiple sclerosis according to new …
The Gateway to Local Adoption Series

Latest content